Lumida
/SHMD
⌘K
SHMD

SHMD

SHMD
$4.25USD-1.39%-0.06 today

MARKET CAP

303.0M

P/E (TTM)

FWD P/E

DAY RANGE

$4 – $4

52W RANGE

$2
$11

The case for & against

Bull & Bear analysis

Bearish

SCHMID Group N.V. (Ticker: SHMD) operates as a prominent equipment provider in the semiconductor and advanced packaging industry, focusing on innovative production technologies for high-performance computing and AI applications. With over 60 years of experience, Schmid is navigating towards advanced packaging solutions, capitalizing on substantial market demand as the industry shifts from wafer-level to panel-level packaging. Their competitive positioning is reinforced by strong client relationships and a reputation for high-quality, complex products, particularly in the context of AI-driven infrastructure.

Bull says

  • FY2026 revenue guidance above €100 M, H1 2025 at €60 M.
  • €140 M order intake projected for FY2026; 60% tied to AI infrastructure.
  • Sprint program targets ≥€4 M in run-rate cost savings to expand EBITDA margins.
  • $30 M convertible financing closed; planning €31 M debt reduction to strengthen balance sheet.
  • Panel-level packaging market set to grow 3–4× by 2030, driving long-term demand.
  • Strong growth factors and positive momentum support valuation and capital upside.

Bear says

  • H1 2025 revenue €60 M fell short as tariff uncertainty delayed orders.
  • Negative earnings yield and weak profitability factors hinder return prospects.
  • Leverage remains elevated despite planned €31 M debt reduction initiative.
  • Order backlog €49 M may not offset capacity bottlenecks and execution risks.
  • Stock down 23.9% recently; high short interest signals investor skepticism.
  • Negative earnings revisions reflect analyst skepticism on near-term outlook.

Earnings Call · Q4 2025 · Mgmt. Guidance

Updated 05-21-2026neutral

Transcript signals

Bull points

  • We secured solid financing for the group through our $30 million convertible announced in January.
  • we just announced a $30 million standby equity line, which allows us to secure funding if and when such funding is required.
  • despite the challenging first half, we ended 2025 with a very strong order intake of more than 90 million euros and a very healthy order book of 51 million euros.

Bear points

  • there was a nine-month strategic review period on a potential M&A transaction until October, which meant that no capital was raised either during the de-SPAC process completed in April 2024 or since the de-SPAC process.
  • total working capital moved to negative €30 million year-end.
  • we can achieve these savings mostly through short labor programs and other voluntary headcount reductions and keep one-time reduction costs to approximately half a million euros.
Read full transcript analysis ›